Global and United States Targeted Drug HER2 Inhibitors for NSCLC Market Report & Forecast 2023-2028

Report ID: 1869221 | Published Date: Jan 2025 | No. of Page: 72 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Targeted Drug HER2 Inhibitors for NSCLC Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size for the Year 2017-2028
        1.2.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size for the Year 2017-2028
    1.3 Targeted Drug HER2 Inhibitors for NSCLC Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Targeted Drug HER2 Inhibitors for NSCLC in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Targeted Drug HER2 Inhibitors for NSCLC Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Targeted Drug HER2 Inhibitors for NSCLC Market Dynamics
        1.4.1 Targeted Drug HER2 Inhibitors for NSCLC Industry Trends
        1.4.2 Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
        1.4.3 Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
        1.4.4 Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Targeted Drug HER2 Inhibitors for NSCLC by Type
    2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Segment by Type
        2.1.1 Afatinib
        2.1.2 Trastuzumab
        2.1.3 Other
    2.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017, 2022 & 2028)
    2.3 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2028)
    2.4 United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017, 2022 & 2028)
    2.5 United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2028)
3 Targeted Drug HER2 Inhibitors for NSCLC by Application
    3.1 Targeted Drug HER2 Inhibitors for NSCLC Market Segment by Application
        3.1.1 Squamous Cell Carcinoma of NSCLC
        3.1.2 Adenocarcinoma of NSCLC
        3.1.3 Large Cell Carcinoma of NSCLC
    3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017, 2022 & 2028)
    3.3 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2028)
    3.4 United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017, 2022 & 2028)
    3.5 United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2028)
4 Global Targeted Drug HER2 Inhibitors for NSCLC Competitor Landscape by Company
    4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Company
        4.1.1 Top Global Targeted Drug HER2 Inhibitors for NSCLC Companies Ranked by Revenue (2021)
        4.1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Player (2017-2022)
    4.2 Global Targeted Drug HER2 Inhibitors for NSCLC Concentration Ratio (CR)
        4.2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Targeted Drug HER2 Inhibitors for NSCLC in 2021
        4.2.3 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Targeted Drug HER2 Inhibitors for NSCLC Headquarters, Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Targeted Drug HER2 Inhibitors for NSCLC Headquarters and Area Served
        4.3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Companies Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Company
        4.5.1 Top Targeted Drug HER2 Inhibitors for NSCLC Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2020, 2021 & 2022)
5 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region
    5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2017-2028)
        5.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region: 2017-2022
        5.2.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.1.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.3.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.4.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Boehringer-Ingelheim
        7.1.1 Boehringer-Ingelheim Company Details
        7.1.2 Boehringer-Ingelheim Business Overview
        7.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Introduction
        7.1.4 Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
        7.1.5 Boehringer-Ingelheim Recent Development
    7.2 Roche
        7.2.1 Roche Company Details
        7.2.2 Roche Business Overview
        7.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Introduction
        7.2.4 Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
        7.2.5 Roche Recent Development
    7.3 Mylan
        7.3.1 Mylan Company Details
        7.3.2 Mylan Business Overview
        7.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Introduction
        7.3.4 Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
        7.3.5 Mylan Recent Development
    7.4 Biocon
        7.4.1 Biocon Company Details
        7.4.2 Biocon Business Overview
        7.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Introduction
        7.4.4 Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
        7.4.5 Biocon Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Targeted Drug HER2 Inhibitors for NSCLC Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Targeted Drug HER2 Inhibitors for NSCLC Market Trends
    Table 3. Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
    Table 4. Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
    Table 5. Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
    Table 6. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Targeted Drug HER2 Inhibitors for NSCLC Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Share by Player, 2017-2022
    Table 13. Global Targeted Drug HER2 Inhibitors for NSCLC Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Targeted Drug HER2 Inhibitors for NSCLC by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2021)
    Table 15. Top Players of Targeted Drug HER2 Inhibitors for NSCLC in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Targeted Drug HER2 Inhibitors for NSCLC Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Targeted Drug HER2 Inhibitors for NSCLC Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Targeted Drug HER2 Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Targeted Drug HER2 Inhibitors for NSCLC Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Targeted Drug HER2 Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Targeted Drug HER2 Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Targeted Drug HER2 Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Boehringer-Ingelheim Company Details
    Table 31. Boehringer-Ingelheim Business Overview
    Table 32. Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product
    Table 33. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 34. Boehringer-Ingelheim Recent Development
    Table 35. Roche Company Details
    Table 36. Roche Business Overview
    Table 37. Roche Targeted Drug HER2 Inhibitors for NSCLC Product
    Table 38. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 39. Roche Recent Development
    Table 40. Mylan Company Details
    Table 41. Mylan Business Overview
    Table 42. Mylan Targeted Drug HER2 Inhibitors for NSCLC Product
    Table 43. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 44. Mylan Recent Development
    Table 45. Biocon Company Details
    Table 46. Biocon Business Overview
    Table 47. Biocon Targeted Drug HER2 Inhibitors for NSCLC Product
    Table 48. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 49. Biocon Recent Development
    Table 50. Research Programs/Design for This Report
    Table 51. Key Data Information from Secondary Sources
    Table 52. Key Data Information from Primary Sources
List of Figures
    Figure 1. Targeted Drug HER2 Inhibitors for NSCLC Product Picture
    Figure 2. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size 2017-2028 (US$ Million)
    Figure 4. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size 2017-2028 (US$ Million)
    Figure 6. United States Targeted Drug HER2 Inhibitors for NSCLC Market Share in Global 2017-2028
    Figure 7. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered
    Figure 8. Product Picture of Afatinib
    Figure 9. Product Picture of Trastuzumab
    Figure 10. Product Picture of Other
    Figure 11. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type in 2022 & 2028
    Figure 12. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
    Figure 14. United States Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type in 2022 & 2028
    Figure 15. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2017-2028)
    Figure 17. Product Picture of Squamous Cell Carcinoma of NSCLC
    Figure 18. Product Picture of Adenocarcinoma of NSCLC
    Figure 19. Product Picture of Large Cell Carcinoma of NSCLC
    Figure 20. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application in 2022 & 2028
    Figure 21. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
    Figure 23. United States Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application in 2022 & 2028
    Figure 24. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2017-2028)
    Figure 26. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
    Figure 55. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
    Figure 56. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
    Figure 57. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer-Ingelheim
Roche
Mylan
Biocon
Frequently Asked Questions
Targeted Drug HER2 Inhibitors for NSCLC report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Targeted Drug HER2 Inhibitors for NSCLC report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Targeted Drug HER2 Inhibitors for NSCLC report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports